QNRX

NASDAQ 已收盘

Quoin Pharmaceuticals

3.28 USD
▼-0.08-2.35%
盘后 3.42 +4.27%
2026-11-20
市值
$15.76M
市盈率
—
EPS
-17.30
股息率
—
52 周区间
3.18 – 23.50
成交量
11.25K
Beta
1.64
目标价
19.89
52W 低 3.1852W 高 23.50
价格走势

公司简介

Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company’s lead product is QRX003, a topical lotion, which is in phase 2 to treat netherton syndrome (NS); phase 1 in to treat peeling skin syndrome; and in pre-clinical stage to treat SAM syndrome and ichthyosis. It also develops QRX008 for the treatment of scleroderma, which is in pre-clinical stage; and QRX009, to treat microcystic lymphatic ...